Fibroblast Growth Factor 23

Fibroblast Growth Factor 23 (FGF23) is a hormone made mainly by osteocytes in bone. In Anatomy and Physiology I, it helps control phosphate excretion in the kidneys and lowers active vitamin D levels.

What is Fibroblast Growth Factor 23?

Fibroblast Growth Factor 23, or FGF23, is a hormone made mostly by osteocytes in bone that tells the kidneys to get rid of more phosphate. In Anatomy and Physiology I, you usually meet it as part of the body’s mineral homeostasis system, where bone is not just a support tissue but also an endocrine organ.

FGF23 acts mainly on the kidneys. When phosphate levels rise, osteocytes release more FGF23, and the kidneys respond by reabsorbing less phosphate in the renal tubules. That means more phosphate leaves the body in urine instead of staying in the blood. This matters because phosphate has to stay in a narrow range for normal bone mineralization, cell function, and overall electrolyte balance.

FGF23 also lowers the production of 1,25-dihydroxyvitamin D, the active form of vitamin D. That has a second downstream effect, because active vitamin D normally increases intestinal absorption of calcium and phosphate. So FGF23 does not just affect the kidney directly, it also changes how much mineral enters the bloodstream from the digestive tract.

A simple way to think about it is this: if phosphate is running high, FGF23 helps push it down by sending two messages at once, dump more phosphate in urine and make less active vitamin D. That keeps phosphate from building up and helps protect tissues from mineral imbalance.

This is why FGF23 shows up in lessons about bones, kidneys, and endocrine signaling together. The bone detects the mineral state of the body, then signals the kidney to correct it. That back-and-forth is a good example of homeostasis in action, and it shows how one organ can have a secondary endocrine function beyond its main structural job.

Why Fibroblast Growth Factor 23 matters in Anatomy and Physiology I

FGF23 matters because it ties together the skeletal system, urinary system, and endocrine control of minerals. In Anatomy and Physiology I, that connection helps explain why bones are not passive storage structures. They actively sense phosphate status and send hormonal signals that change kidney function.

It also gives you a cleaner way to understand mineral balance problems. If phosphate stays too high, the body has to respond or the extra phosphate can contribute to bone problems and abnormal mineral deposition. FGF23 is part of that response, so it is one of the hormones you can point to when explaining how the body prevents hyperphosphatemia.

You may also see FGF23 used to explain why vitamin D regulation and phosphate regulation are linked. When active vitamin D drops, phosphate handling changes too, which affects bone mineralization and calcium-phosphate balance. That makes FGF23 useful in diagrams, case questions, and short-answer explanations about homeostasis.

A lot of A&P questions about this topic are really asking whether you can trace the signal from bone to kidney and predict the result. If FGF23 rises, phosphate excretion rises and active vitamin D falls. If the kidneys are not working well, that balance gets harder to maintain, which is why the hormone comes up in kidney-related mineral disorders.

How Fibroblast Growth Factor 23 connects across the course

Osteocytes

Osteocytes are the bone cells that produce FGF23. This connection matters because it shows bone acting as an endocrine tissue, not just a structural one. If you remember that osteocytes sense mineral status and release hormone signals, FGF23 makes much more sense in the broader homeostasis picture.

Phosphate

FGF23 exists to regulate phosphate balance. When phosphate is high, FGF23 pushes the kidneys to excrete more of it, which lowers blood phosphate. That makes phosphate one of the easiest clues for figuring out why FGF23 is being released and what effect it is having.

1,25-Dihydroxyvitamin D

FGF23 suppresses the active form of vitamin D, which changes how much calcium and phosphate are absorbed from the gut. This link helps you connect bone-kidney signaling to intestinal mineral absorption. If you trace the pathway, you can see how one hormone influences more than one organ system.

Adipose Tissue

Adipose tissue is another example of a tissue with endocrine activity, even though its main job is energy storage. Comparing adipose tissue to bone helps you see a recurring A&P pattern: organs can secrete hormones that affect distant targets, not just perform their primary physical function.

Is Fibroblast Growth Factor 23 on the Anatomy and Physiology I exam?

A quiz item or short-answer prompt may ask you to trace what happens when FGF23 rises. The move is to connect the source, osteocytes in bone, to the target, the kidneys, and then state the result: less phosphate reabsorption, more phosphate lost in urine, and less active vitamin D made.

You may also see a scenario asking why a person with phosphate retention has elevated FGF23. In that case, explain it as a homeostatic response, not as a random hormone change. If the kidneys cannot clear phosphate well, the body increases FGF23 in an attempt to restore balance.

On a diagram or labeling question, identify FGF23 as an endocrine signal from bone that affects mineral handling. If the question mentions vitamin D, do not stop at calcium, because FGF23 also changes phosphate regulation through the kidney and the gut.

Fibroblast Growth Factor 23 vs 1,25-Dihydroxyvitamin D

These are easy to mix up because both affect mineral balance, but they do opposite jobs in the pathway. 1,25-dihydroxyvitamin D raises intestinal absorption of calcium and phosphate, while FGF23 lowers active vitamin D production and promotes phosphate loss in urine. One is a vitamin hormone that increases mineral availability, the other is a bone hormone that helps reduce phosphate.

Key things to remember about Fibroblast Growth Factor 23

• Fibroblast Growth Factor 23 is a hormone made mostly by osteocytes in bone.

• Its main target is the kidney, where it increases phosphate excretion in urine.

• FGF23 also lowers 1,25-dihydroxyvitamin D, which changes mineral absorption and balance.

• It is part of homeostasis, especially when the body needs to prevent phosphate from building up.

• In Anatomy and Physiology I, FGF23 is a clear example of bone functioning as an endocrine organ.

Frequently asked questions about Fibroblast Growth Factor 23

What is Fibroblast Growth Factor 23 in Anatomy and Physiology I?

Fibroblast Growth Factor 23 is a hormone made mainly by osteocytes in bone. It tells the kidneys to excrete more phosphate and reduces production of active vitamin D, helping keep mineral levels stable.

What does FGF23 do to phosphate?

FGF23 lowers blood phosphate by making the kidneys reabsorb less of it. More phosphate is then lost in urine, which helps prevent hyperphosphatemia. That is the main job you should remember for this term.

How is FGF23 different from vitamin D?

Vitamin D, especially 1,25-dihydroxyvitamin D, increases absorption of calcium and phosphate from the intestine. FGF23 does the opposite kind of regulation by lowering active vitamin D and promoting phosphate excretion, so the two work in the same system but in different directions.

Why is FGF23 considered an endocrine signal from bone?

Because the bone is releasing a hormone that travels through the blood to affect a distant target, mainly the kidneys. That is what makes it a secondary endocrine function, even though the skeleton’s main job is support and protection.